Patti Moore

Survival without Common Toxicity Criteria Grade 3/4 Toxicity for Pemetrexed Compared with Docetaxel in Previously Treated Patients with Advanced Non-small Cell Lung Cancer (NSCLC): A Risk-Benefit Analysis

Jean-Louis Pujol, Sofia Paul, Nadia Chouaki et al. · Journal of Thoracic Oncology · 2007 · 66 citations · Full text

Oncology, Risk-benefit Analysis, Medicine +7

Lung Cancer Symptom Scale Outcomes in Relation to Standard Efficacy Measures: An Analysis of the Phase III Study of Pemetrexed Versus Docetaxel in Advanced Non-small Cell Lung Cancer

Filippo de Marinis, José Rodrigues Pereira, Frank V. Fossella et al. · Journal of Thoracic Oncology · 2008 · 51 citations

Oncology, Pulmonary Care, Advanced Lung Disease +11

Pemetrexed Therapy in Elderly Patients With Good Performance Status: Analysis of Two Phase III Trials of Patients With Nonsquamous Non–Small-Cell Lung Cancer

Cesare Gridelli, Thomas Brodowicz, Corey J. Langer et al. · Clinical Lung Cancer · 2012 · 35 citations

Oncology, Elderly Patients, Phase Iii Trials +9

An assessment of governance of marine and coastal resources on Koh Tao, Thailand

Suvaluck Satumanatpan, Patti Moore, Angela Lentisco et al. · Ocean & Coastal Management · 2017 · 24 citations

Coastal Management, Marine Resource, Ocean Space Utilization +8

Tobacco Cessation Motivations, Preferences, and Barriers Among Rural Smokers: Implications for Optimizing Referrals in Clinical Practice

Kelly A. Hirko, Patti Moore, Lawrence C. An et al. · AJPM Focus · 2022 · 10 citations · Full text